comparemela.com

Latest Breaking News On - Tetsuya hamaguchi - Page 1 : comparemela.com

Oxaliplatin Add-On Not Recommended for Elderly With Colon Cancer

The addition of oxaliplatin does not extend progression-free survival in elderly patients with metastatic colorectal cancer and in fact, can lead to more severe adverse events.

United statesRoche genentechTetsuya hamaguchiGabriel brooksAmerican society for clinical oncologySaitama medical university international centerNational cancer center researchAmerican society for radiation oncologyAgency for medical researchSociety of surgical oncologyHitchcock norris cotton cancer centerDevelopment fundAmerican gastroenterological associationClinical cancer researchDartmouth hitchcock norris cotton cancer centerPerformance status

Oxaliplatin Does Not Benefit Older Patients With Metastatic Colorectal Cancer

Adding oxaliplatin to fluoropyrimidine plus bevacizumab did not benefit older patients with metastatic colorectal cancer, a phase 3 trial suggests.

Tetsuya hamaguchiSaitama medical university international centerCancers symposiumCancer therapy advisor

vimarsana © 2020. All Rights Reserved.